Actively Recruiting
Pregnancy Registry for Women with Tuberous Sclerosis Complex and Lymphangioleiomyomatosis and Their Children
Led by David M. Ritter · Updated on 2026-01-23
300
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to collect detailed information about Tuberous Sclerosis Complex TSC and Lymphangioleiomyomatosis LAM in pregnant women and their children. TSC is caused by mutations affecting the mTOR pathway, leading to multiple organ involvement and risks such as autism, epilepsy, intellectual disability, and various tumors. LAM mostly affects women and is linked to TSC gene mutations. The goal is to help doctors develop better care guidelines for pregnant women with these conditions and improve fetal screening for TSC. Participants who are pregnant women with TSC or LAM will complete monthly online surveys to report on pregnancy progress, health changes, medication use, and care details. For infants enrolled after birth, clinical information will be collected and reviewed up to 5 years of age. This observational registry focuses on monitoring and gathering data without administering specific treatments. Throughout the study, researchers will monitor medication adherence, dosing, and side effects related to mTOR inhibitors during pregnancy and for six months after delivery. They will also assess maternal and fetal health outcomes including behavioral and mental health postpartum. Imaging and clinical reviews for infants will continue up to age five, allowing long-term observation of TSC effects. Participation may last from pregnancy through early childhood follow-up.
CONDITIONS
Brief Title
Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry)
Research Team
M
Molly S Griffith, BA
A
Adrienne Victory
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here